Pharma group asks USTR to drop India from watch list
12-02-2019
Indian court rules in Sanofi’s favour in trademark suit
21-11-2018
ericsphotography / iStockphoto.com
India’s Department of Pharmaceuticals (DoP) has removed a price cap from a range of essential patented drugs used in the treatment of rare diseases.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
India, Department of Pharmaceuticals, price cap, patents, orphan drugs, All India Drug Action Network
